An old threat to public health is resurfacing amidst COVID-19 worries

By Sally Greenberg, NCL Executive Director

While all of us have learned to adapt to the ‘new’ ways to stay healthy we can’t let our need to avoid contact with others get in the way of the important steps we have always taken to keep disease at bay; staying up to date on vaccinations.

Since the COVID-19 pandemic hit, most of us have dutifully complied with stay-at-home orders to avoid contracting the virus. While that is critically important, there are other diseases that we must guard against. While the world awaits a COVID-19 vaccine, we need to keep ourselves and our families safe by protecting overall health. This includes taking steps to diminish the risk of other dangerous outbreaks that would weaken our immune systems and put additional strain on the healthcare system.

Before the coronavirus, low vaccination rates were already a concern for many populations. But in the last several weeks, we have been alarmed to learn that the numbers of people receiving vaccinations—from the very young to the very old—have plummeted. That is extremely worrisome for public health officials.

In fact, prominent organizations like the World Health Organization (WHO) and the National Foundation for Infectious Diseases (NFID) have stressed the importance of maintaining vaccination against illnesses like the flu and pneumonia, which affect lung health during the pandemic. This is even more important for those with underlying conditions and those over the age of 65 who are more vulnerable to these diseases.

Early in the pandemic, we thought children might be spared from much of the outbreak. That turns out not to be true. Children need their vaccinations more than ever! Time has proven that there is still much we don’t know about the Coronavirus and how it affects the vulnerable—so staying up-to-date on pediatric vaccines is equally important.

Hesitation to visit the doctor’s office is completely understandable, but I can speak from personal experience that our health care providers are making doctor visits very safe.

When I visited the doctor on a non-coronavirus issue, they staggered patient appointments so patients never had to share a waiting room; everyone wore a mask; we observed 6-foot social distancing; there was an abundance of soap and water and hand sanitizer. The staff at the office was exceptional. They were organized, completely protected with all of the proper PPE, and very focused on making sure that I—the patient—felt safe and secure.

The best advice? Call ahead to ask your health care provider about the precautions they have in place and the best timing for a visit to update your vaccines. Adults, get your shingles, pneumococcal pneumonia, and flu shots. You don’t want those illnesses! And every child needs the array of measles, mumps, tetanus, diphtheria, whooping cough, and other vaccines recommended by the Centers for Disease Control (CDC) for children.

As we continue to live in this new world, we have a responsibility to ourselves, to our families, and our communities to stay as healthy as possible. Modern medicine’s gift to humankind is an array of extremely safe and effective childhood and adult vaccines to prevent diseases that once, collectively, have killed billions globally. As the COVID-19 pandemic has shown, we are lucky to have these vaccines. They keep us safe and healthy. We all have to do our part and get vaccinated from preventable diseases.

NCL: Annual in-office eye exams help diagnose potential problems

May 4, 2020

Contact: National Consumers League – Carol McKay, carolm@nclnet.org, (412) 945-3242 or Taun Sterling, tauns@nclnet.org, (202) 207-2832

Washington, DC–The National Consumers League (NCL) has long recommended an annual, in-person eye exam as part of consumers’ annual health and wellness routines. An eye examination with an eye doctor ensures not only correct eyeglass and contact lens prescriptions, but also the opportunity for important preventive care as the eyes are a window into our overall health. An eye doctor, whether a primary eye care doctor of optometry or an ophthalmologist, can diagnose potentially hundreds of conditions during an exam, including diabetes, cancer, and macular degeneration. Through an eye exam, these doctors can catch an illness or disease early and treat it right away, making this care a critical part of our preventive care toolbox.

But now with COVID-19 keeping many of us at home, companies claiming to offer at-home vision tests are ramping up their marketing, despite the fact that there is no U.S. Food and Drug Administration- (FDA) approved at-home device that people can use to self-conduct a vision assessment, let alone a full eye examination. These devices have not been proven to even provide an accurate vision prescription. Consumers need to be wary of products that mistakenly claim that their at-home devices can provide an eye exam or a vision prescription and should instead consult their eye doctors who are available to help provide safe solutions.

NCL applauds state attorneys general for taking action and the media for publishing articles about the dubious effectiveness and potential dangers that at-home vision tests or devices present. It’s been important to tell consumers to be aware of false marketing promises.

As states begin to reopen health care access, eye doctors across the country are beginning to safely provide routine eye health examinations once again. Patients looking to schedule their annual eye examinations or update their prescriptions should contact their eye doctors, who are employing protocols to protect everyone’s health during this public health emergency.

Although the COVID-19 pandemic is bringing out the best in many companies across our country, there are those few who are taking this opportunity to mislead and misinform the public. NCL wants to remind consumers to be aware and understand that there’s no substitute for an annual, in-person comprehensive eye exam or for the doctor-patient relationship that’s at the heart of healthy outcomes, especially when it concerns our precious eye health and vision. When it comes to your eyes, you don’t fool around!

###

About the National Consumers League

The National Consumers League, founded in 1899, is America’s pioneering consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

COVID-19 shows us the extraordinary importance of vaccines

By Sally Greenberg, NCL Executive Director

What a bittersweet moment for advocates like NCL fighting off the lies and falsehoods spread by the anti-vaccine movement, as we start to see some anti-vaxxers changing their tune while still others continue to hold firm to their dangerously misinformed views. The reality is that a vaccine to fight COVID-19 would have prevented the global devastation caused by this disease and prevented the loss of nearly 60,000 lives and 27 million jobs nationwide.

Over the past decade, NCL has become a champion of vaccines and their extraordinary power to protect humans around the globe safely and effectively from many deadly diseases. Illnesses such as polio, tetanus, measles, smallpox, flu, mumps, measles, tuberculosis, human papillomavirus (HPV), that have maimed and killed billions of people, have ebbed or been eradicated, thanks to vaccines.

As a commitment to our advocacy, NCL has twice testified before the Advisory Committee on Immunization Practices (ACIP) in support of the meningitis B and pneumonia vaccine (PCV-13). In our testimonies, NCL called for universal vaccination for children and adults, reaffirming vaccines as one of the greatest gifts modern medicine has provided to the human race.

Our comments also challenged the outrageous falsehoods spread by the small but vocal anti-vaccine movement. Their claims of vaccines causing autism have been debunked over and over, yet their power to scare parents lives on.

I grew up with an uncle who contracted polio a year before the vaccine was introduced. His illness was utterly devastating. Having a quadriplegic member of the family meant that from a very young age I developed an appreciation for vaccines and was comforted in knowing that I didn’t have to worry as my grandparents did about losing my son to a terrible disease.

Now Americans wait anxiously for labs and drug companies to develop a safe and effective COVID-19 vaccine. This could take many months due to our remarkably high standards of safety and efficacy. I certainly hope this calamitous COVID-19 outbreak will be the death knell of the anti-vaccine movement. Sadly, I fear it will not.

COVID-19, what could it cost you?

Nissa Shaffi

By Nissa Shaffi, NCL Associate Director of Health Policy

As the nation continues to navigate the COVID-19 pandemic, another top-of-mind concern is the cost associated with both testing and treatment for the illness. Between the boldness of certain state officials relaxing restrictions and the rapid ascension of cases, exposure to COVID-19 will inevitably rise.

The reassuring news is that the majority of Americans diagnosed will be able to recover from home. But what if you’re among the 15 percent that will need hospitalization? This subset of the population will require the most acute care, including admission into an intensive care unit and use of a ventilator. Between testing and treatment, there are a lot of factors for the consumer and patient to consider—outright costs of care, as well as cost-sharing (co-pays, deductibles, out-of-network costs, and more)—we did some of the research below.

Testing

  • Affordable Care Act (ACA)-compliant Plans: Under the Families First Coronavirus Response Act, all comprehensive health plans (individual, employer-sponsored, or ACA marketplace plans), must cover testing for COVID-19 at 100 percent.
  • Medicare & Medicaid: Testing is covered at 100 percent for Medicare and Medicaid.
  • Uninsured: Testing will be covered at 100 percent by Medicaid, as mandated by the CARES Act.
  • Non-ACA-Compliant Plans: Testing coverage may vary for consumers with non-ACA-compliant plans (i.e., short-term plans), as these plans are not subject to the protections found in the ACA.

Apart from non-ACA plans, there’s testing done in an emergency room, urgent care, or physician’s office, and all that should be covered. In addition, the health plan cannot impose prior authorization or cost-sharing restrictions (i.e., copays, deductibles, coinsurance) on the patient. Of course, access to testing is currently limited to those with symptoms or those working in health care facilities or other consumer-facing businesses. There are still strict criteria established by the Centers for Disease Control and Prevention (CDC).[1]

Treatment

Newly passed emergency bills do not address coverage of treatment. The Kaiser Family Foundation estimates that out-of-pocket costs for COVID-19 treatment for someone insured on an employer-based health plan could run upwards of $10,000, provided that there are no complications. For patients that require more acute care, costs could reach $20,000.

ACA-Compliant Plans: Health plans are not required to fully cover the cost of positive tests. A majority of the treatments for COVID-19 under ACA-compliant plans will qualify as essential health benefits, and as such will be covered. However, every state defines its own criteria for essential health benefits, and it is possible that some treatments will not be covered, based on where you live. Furthermore, coverage may vary depending on the type of group health plan you have (large vs. small).

Cost-sharing will also likely be imposed. Marketplace plans are required to cap maximum out-of-pocket costs for services covered in-network. In 2020, the maximum out-of-pocket cap is $8,150, meaning that if your care is deemed medically necessary, your out-of-pocket costs should not exceed that amount. Some plans have offered to cover patient-cost sharing for out-of-network care for COVID-19 in the absence of in-network availability. As an emergency course of action, several health plans have waived out-of-pocket costs like copays and coinsurance associated with treatment for COVID-19. To see where your health plan stands, click here.

Medicare and Medicaid: Medicare Part A (hospital stays) and Part B (doctor’s visits) will continue to charge copays and deductibles. The deductible for a 60-day hospital stay under Part A is $1,408. For Part B, the annual deductible is approximately $200. Cost-sharing related to Medicare Advantage and Medicaid plans will depend on your individual plan.

Uninsured: The Trump Administration has announced that part of the $100 billion of the $2 trillion appropriated for COVID-19-related relief in the CARES Act will be dedicated to reimbursing providers who treat uninsured patients. Provisions within the law include treatment for primary diagnosis of COVID-19 in a variety of settings, both emergency and non-emergency transportation, and post-acute care. Services that will be excluded from coverage include hospice and outpatient prescription drugs.

While further guidance is pending, Health and Human Services Secretary Alex Azar has clarified the following: “as a condition of receiving funds under this program, providers will be forbidden from balance billing the uninsured for the cost of their care.” This caveat reinforces that providers would get reimbursed at Medicare rates for delivery of uncompensated care and cannot balance bill the difference between Medicare reimbursement and the hospital’s charges.

In addition to the above, the law prohibits hospitals from charging patients beyond what they would pay in-network or what Medicare pays. The mandate against surprise billing serves to protect patients covered by government programs, employer-based plans, and self-purchased insurance.

Also, the growing loss of employer-based health coverage has prompted several states to extend their special enrollment periods to accommodate newly unemployed/uninsured patients during the pandemic. To see if you qualify for a special enrollment period, click here.

Non-ACA-Compliant Plans: Off-marketplace plans are not regulated by the ACA, and this could affect coverage for COVID-19-related treatment, where there is a possibility that treatment may not be covered outright. Examples of non-ACA plans include short-term health, fixed indemnity, and critical illness plans. These plans do not qualify for minimum essential coverage and are insufficient on their own, in our view.

Understanding insurance benefits can be daunting under ideal circumstances, let alone during a global health crisis. Consumers need enhanced accessibility and coverage now more than ever and NCL commends health plans for acting promptly to waive various cost-sharing measures. NCL urges Congress to continue to fortify and provide clear guidance for consumer protections, to ensure that they are not left stranded without vital care. Consumers, please know that there are COVID-19-related resources available to you—for more information, click here.

[1] To find a drive-thru testing site near you, click here.

A few out-of-the-box consumer tips for staying safe from coronavirus

By Sally Greenberg, NCL Executive Director

At the National Consumers League, we’re all about protecting consumers during this terrible coronavirus pandemic. Most of us understand that we need to social distance, work from home if possible, wear masks when going out—especially on trips to the grocery or drug store—and not gather in groups larger than 10.

Yesterday, I had a conversation with my doctor to hear what she is telling patients about testing kit availability for both the virus and antibodies test, and to hear what other advice she is giving. She told me some things I’d like to pass along:

  • The Food and Drug Administration (FDA) relaxed requirements for developing COVID-19 tests and as a result, there are many kits to test for antibodies available for sale but very few—4 to date—have been approved by the FDA as high-quality and accurate. Consumers, don’t waste your money on phony or inaccurate tests.
  • Neither she nor any doctor she knows has access to the high-quality antibody tests. The good news is that there is plenty of capacity for testing people with COVID-19 symptoms. That was not always the case, so it’s a hopeful sign that there will be high-quality antibody tests available when the industry really ramps up.
  • For those who’ve had COVID-19 and recovered, the presence of antibodies alone is not sufficient. The best tests will show the level of antibody protection and whether those levels meet the threshold to protect us from contracting the disease.
  • Contact tracing is critical to curb this illness. My doc has traveled throughout the world and lived abroad for periods of time. She says without contact tracing we cannot hope to contain the disease. Former Peace Corp workers and health care providers who have worked around the world have this down to a science. Anyone who has been exposed to someone with COVID-19 has to go into quarantine for 14 days. My doc says that USAID has been doing this for many years when there’s an outbreak and it’s critical to containing the disease.

Until the appropriate infrastructure to test and contact trace for COVID-19 is established, my doctor suggested the following:

  • She recommends taking extra Vitamin C, extra Vitamin D, and Zinc. As a result, I’m taking two multivitamins each day based on the level of those three she is recommending.
  • She recommends getting some sun for at least 30 minutes a day to boost your immune system. Hopefully, most consumers are in climates that provide access to sunshine and can get outside. We know that is hard for people in apartment buildings or who have disabilities or live alone and don’t have support.
  • Finally, don’t assume you’ve been exposed and have antibodies just because you haven’t gotten sick. Until we have a vaccine, along with robust testing and contact tracing in place, we must continue to social distance.

 

Nation’s pioneering consumer-worker organization demands massive COVID-19 testing production, universal testing

April 23, 2020

Contact: National Consumers League – Carol McKay, carolm@nclnet.org, (412) 945-3242 or Taun Sterling, tauns@nclnet.org, (202) 207-2832

Washington, DC –The National Consumers League (NCL), the nation’s oldest consumer and worker advocacy organization, is demanding that the federal government put its support behind massive COVID-19 test production and, as quickly as is feasible, put in place a testing protocol for every citizen so that America can get back to work.

“There are calls across the country to reopen businesses; we understand and share that frustration,” said NCL Executive Director Sally Greenberg. “However, as we are currently not allowing tests for people who are asymptomatic—and because 25 percent of people who carry the virus don’t show symptoms—doing so would be reckless. It’s a Catch-22. Until everyone is tested, we can’t send symptom-free people back into the world. So the government’s first order of business must include giving America’s labs and drug companies the goal and the means to produce rapid-response testing for every American within the next month.”

NCL has laid out the following recommendations:

Meet the need for testing in clinics and doctors’ offices

The Food and Drug Administration (FDA) must oversee the process of improving techniques and reliable, accurate test production. Many labs are working on this, addressing the immediate need for care providers to have enough, high-quality tests.

“The Senate has voted to include $25 billion for the clinical labs that make the tests in the next COVID legislative package” said Greenberg. “That is welcome news because states cannot do this alone; they end up competing against each other for tests and other supplies.”

As Maryland Governor Larry Hogan (R-MD) said this week, “Every governor in America has been pushing and fighting and clawing to get more tests, not only from the federal government, but from every private lab in America and from across the world. It’s nowhere where it needs to be.” Virginia Governor Ralph Northam (D-VA) noted that the President’s claims that the country has enough tests for the virus are “delusional.”

Clearly, quality is paramount. The serious stumbles at such premier institutions as the Centers for Disease Control and Prevention (CDC) cannot continue. “The federal government must continue to support and expand the production of quality tests, and at capacity to meet the current needs of care providers,” said Greenberg.

Universal testing

As stated above, though, in order to get people back out to restart the economy, we cannot only test those who show serious symptoms and go to care providers to get tested. We must develop tests that can be self-administered, and in adequate numbers so that each person can test for COVID before leaving the home on any given day.

“Millions of workers have to take drug tests every day to keep their jobs; those tests are rapid-response. Consumers can buy rapid response tests for strep throat and pregnancy,” said Greenberg. “Those are approved FDA products that are tested for accuracy and safety. We must get to a rapid response COVID-19 home test as soon as possible.”

In order to determine who has COVID-19 and should be quarantined, every American must be able to test for the virus on a regular basis. Those who test positive, with or without symptoms, go into quarantine for 14 days, as do the people in that individual’s household. Those who test negative are cleared to go out in the world to get the trains running again. This would call for hundreds of millions of tests to enable on-going testing, as it is the only path forward at this time.

And the technology is not “pie-in-the-sky.” The FDA has already approved one home-test kit, though it requires lab analysis. And BARDA/HHS has funded another company to develop “a rapid antigen and antibody diagnostic to identify current or past SARS-CoV-2 infections in 60 seconds.” We are on the road.

Antibody testing

While it’s not clear how long antibodies create immunity, there is a belief that they at least do so for the short-term. So the next step would be to provide serology testing for people who test negative for COVID-19, using only tests approved by the FDA to ensure quality and accuracy. To date, the FDA has approved only four tests of the many available, but this is an important start.

Those who are determined to have a sufficient level of antibodies should be cleared to go back to work, while still wearing masks and gloves until science has confirmed decisively that antibodies create immunity. If the individuals don’t have antibodies, they would be advised to stay home, but could be cleared to go back to work so long as they test every day before heading out.

Contact tracing

Everyone who tests positive reaches out to everyone they’ve had contact with and those people test for COVID-19. Anyone then testing positive goes into quarantine, and the process repeats.

Use technology to self-surveil

Finally, we need a system for uploading test results each day to our phones – like the bar codes we use to board an airplane – or to carry evidence that we have taken the test, have antibodies to COVID-19, and can work or otherwise go out.  Enforcement would be a new challenge, given our commitment to civil liberties, but one that we can certainly work out.

Longer term: Vaccinate

In a year or more, when a vaccine arrives, 95 percent of Americans will need to be vaccinated to achieve herd immunity and widespread protection.

“Our nation has the know-how and manufacturing infrastructure to produce the millions of tests needed to determine whether someone has the virus,” said Greenberg. “But due to lack of leadership at the top, our testing capacity is still, several months after the outbreak, extremely limited. To date only 3.3 million people have been tested, according to the COVID Tracking Project. That’s about 1 percent of the population. That is simply not enough.”

NCL is demanding that the Federal government respond to the current national Coronavirus emergency as President Roosevelt responded to World War II, and challenge Americans to “harness the efficient machinery of America’s manufacturers” to fight the pandemic.

“We need that call to action now, to challenge America’s labs and drug companies with the goal of producing testing for every American within the next month. Federal health care agencies including CDC, National Institutes of Health (NIH), and FDA should be their partners, and this should be a shared cost,” said Greenberg. “In the midst of the worst unemployment numbers ever seen in American history, and with millions of businesses having their existence threatened, we need federal leadership, expertise, and financial support to make this happen, and we need it now.”

###

About the National Consumers League

The National Consumers League, founded in 1899, is America’s pioneering consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

Universal testing: What is the hold-up?

By Sally Greenberg, NCL Executive Director

During this Covid pandemic, Americans have been incredibly patient and observant of guidelines for social distancing and staying home. But it can’t last forever. Where the heck is the universal testing for Covid-19? We’ve been talking about it for more than two months and yet you can’t get access to Covid-19 testing unless you’re showing symptoms of the virus. If, as experts believe, 25-50 percent of us might be carrying the virus without symptoms, what does that say?

It says we could be spreading the virus without knowing it! And yet we can’t get tested? We need greater accessibility to testing to know where we stand. If everyone could be tested each day to know if we do or don’t have the disease, or be tested for antibodies to Covid-19 to learn that we can fight the disease, we’d be better equipped to know what we’re dealing with and make smart decisions. Such universal testing can get the country back to work, especially at a time when the economy is in even worst shape since the Great Depression with the retail, restaurant, airline, entertainment, film and hotel industries ground to a halt and millions of workers across the economy out of jobs.

And take note: this kind of testing is possible because testing does not need to require a site visit. A study funded by UnitedHealth Group shows people can self-administer a diagnostic test with a much smaller swab, a process that should save potentially thousands of clinicians from being exposed to the virus while at the same time making the testing simpler. The study, which used data from 500 OptumCare patients, comes amid a parade of diagnostic test approvals for Coronavirus following weeks of criticism of the Trump administration and federal agencies for the lack of testing.

On March 24, the “White House Coronavirus Task Force reported in a briefing that “self-swabbing” options were going to be available that week, so the study supports what the federal government is pursuing.” That’s almost a month ago – so where are they?

What’s worse is that the United States is considered well behind other countries when it comes to the availability of testing generally. Why can’t we figure out this solution?

NCL friend and brilliant inventor of the SawStop, a safe table saw, Steve Gass, came up with a novel approach to employ universal testing that would get most of us back to work. His proposal is below. I’ll end with it, because it says it all:

A cure for the coronavirus pandemic already exists. Contrary to our expectation that cures manifest exclusively as biological agents – medicine for the sick or vaccines for the healthy – the cure for this outbreak is technological. From the Oval Office to Kansas kitchens we’re already talking about it, even while failing to recognize its true potential. Those elusive Covid-19 tests, if utilized daily, by every American, have the power to save our lives and our economy within the month.

To date, the U.S. has only employed testing reactively — to diagnosis a disease after symptoms indicate probable infection — which wins us no real advantage when epidemiological evidence indicates up to 40 percent of transmissions occur covertly, days before symptoms appear, and CDC director Dr. Robert Redfield estimates that 25 percent of carriers (and spreaders) may never manifest symptoms at all. We can continue to hide out at home indefinitely, banking on a vaccine in 12-18 months, but public health expert Dr. David Katz calls that a recipe for “ineffectively fighting the contagion even as we are causing economic collapse.”

Instead, we must deploy tests offensively. They must become our mass-produced instruments of war.

Here’s the plan of attack: one month from today, each of us is tested daily for Covid-19, obtaining immediate results. If positive, you isolate at home and instantaneously eliminate the virus’s prime advantage: its ability to stealthily propagate from “people out there shedding the virus who don’t know that they’re infected,” according to infectious diseases expert Dr. Jeffery Shaman. Meanwhile, the healthy among us freely move back out into our communities, flashing our daily health certificates like boarding passes to gain admittance to workplaces, schools, and stores, certain we won’t harm or be harmed by the people with whom we interact. We’ll have immediately shifted, as economists Dr. Paul Romer and Dr. Alan M. Garber insist we must, to a “targeted approach that limits the spread of the virus but still lets most people go back to work.” The very first day we implement universal daily testing and selective isolation commerce resumes, the viral transmission rate plummets, and the virus exponentially decays. The crisis ends.

The challenge in this crisis of scarcity, when too few can access masks let alone diagnostic devices, is to build enough testing units, now, so that all 330 million Americans can be tested daily. This will require at least 1 million community-based machines adapted for parallel processing of multiple tests simultaneously. If we begin tomorrow and labor 24 hours per day it will take just under 12 days to produce and deploy a million machines at a production rate of one unit every second. That’s not just daunting. It’s mind-boggling.

But it’s not impossible.

In May of 1940 the Greatest Generation listened incredulously as President Roosevelt challenged them to “harness the efficient machinery of America’s manufacturers” to produce 50,000 combat aircraft in 12 months to confront the “approaching storm” of a global war – a goal exceeding the total of all planes built in the U.S. since the Wright brothers’ initial 1903 flight. No one believed an 18-ton plane with 450,000 parts and 360,000 rivets in 550 different sizes could be mass produced, let alone efficiently. But our repurposed auto factories did just that, with Ford Motor Co. churning out one bomber per hour at peak production to secure our safety and win the war.

Our nation still has the know-how, the manufacturing infrastructure, and the industrial resources to save ourselves again by building and deploying a million Covid-19 testing units by the end of the month if we make it our highest national priority starting today. We have men and women yearning to go back to work and we must employ them to optimize established supply chains, man assembly lines, and reinvigorate distribution channels. No single state’s factories can meet the one-unit-per-second output required, but pooled national resources can. The cost and effort will be substantial, certainly, but pale in comparison to the misery wreaked if we let a quarter million Americans die instead.

Make no mistake: World War III is upon us. We must once again wake the sleeping giant, mustering America’s industrial might to save ourselves and the whole world with us by rallying resources to test each of us, over and over again, as if our livelihoods and lives depend on it.

Because they do.

—–

Stephen Gass, PhD, J.D., is a physicist, a patent attorney, and the retired President and founder of SawStop, LLC, the nation’s foremost supplier of premium table saws and the world leader in table saw safety. He is the principal inventor on over 100 patents covering electrical and mechanical innovations in power tools.

Safe takeout options under coronavirus

By Nailah John, Linda Golodner Food Safety and Nutrition Fellow

The way we get food now has totally changed due to the Covid-19 virus. Most us around the nation no longer go to our favorite bar or restaurant or stop at the local coffee shop for a bite to eat or to socialize and have a drink. The mandatory closure shutdown of restaurants with the exception of takeout or delivery is our only option of enjoying a meal not cooked at home. Beyond that, we may ask the questions: first is it safe? Second: is it ethical to potentially expose a delivery worker to what we are all trying to avoid the risk of Covid-19?

The answer to the first question is yes, with some caveats. Currently food is not associated with the transmission of Covid-19, according to the CDC and the Food and Drug Administration. However, Vox reports that there is growing evidence of fecal/oral transmission, which means you can ingest the virus shed in feces through inadequate handwashing or contaminated food and water. Therefore, handlers of food who carry the virus can spread the virus to food items. In theory, all restaurants have to follow food safety rules, and there are extra measures that have been put in place due to Covid-19. However, we have seen Chipotle and other restaurants spread infections by poor food handling.

The second question is complicated, but here are some thoughts. Currently delivery workers are in the middle of a pandemic but still have to work to support their families and pay bills. Eater suggests that if customers forego take-out food, delivery workers and restaurants struggling to provide during the crisis could be put out of business.

We recommend ordering take-away food from your favorite restaurants and, even better, support them by buying gift cards for post-pandemic future meals when restaurants re-open.

Your first option is to is use the in-house restaurant delivery option, since third-party apps take commission fees, which reduce the profit for restaurants. Here are some apps that are taking the necessary measures in protecting their workers and helping out the restaurant industry.

  • UberEats is working to provide drivers with disinfectant. With limited supplies they are working with suppliers to source as much as possible. Any delivery worker who is diagnosed with Covid-19 or is individually asked to self-isolate by a public health authority will receive financial assistance for up to 14 days. UberEats customers have the option to choose how they would like their orders delivered, including selecting “leave at door” during checkout. UberEats has also waived the delivery fee for more than 100,000 independent restaurants across the USA and Canada.
  • Postmates launched the Postmates Fleet Relief Fund to help fleet workers cover medical expenses related to Covid-19, regardless of diagnosis. Active members of the fleet who receive a positive diagnosis for Covid-19 or who are required to self-quarantine based on infection may be eligible to access additional funds to offset up to two weeks of lost income while they recover. Postmates has also introduced non-contact deliveries, which allows distancing between customers and delivery workers. Postmates will also waive commission fees for businesses in the San Francisco Bay area.
  • DoorDash (also owns Caviar) is providing financial assistance to eligible delivery workers and Caviar couriers who are diagnosed with Covid-19 or quarantined. DoorDash is consulting with public health officials and working with restaurants to enhance their food preparation protocols. The default delivery method has been changed to the non-contact option to minimize contact between the delivery workers and customers. All new and existing DoorDash partner restaurants will receive commission relief and marketing support.
  • Grubhub is offering a one-time pay adjustment to help with medical expenses and loss of income if a driver tests positive with Covid-19. Grubhub will also support drivers who have been ordered by a public health authority or licensed medical personnel to self-isolate due to a risk of spreading Covid-19, and if a driver’s account has been individually restricted as a result of information provided to Grubhub by a public health authority regarding the risk of spreading Covid-19. Grubhub has also introduced contact-free delivery, which allows customers to request having their delivery left at the front door to avoid less contact.
  • On March 9, Instacart introduced a new sick pay policy that all part-time employees including in-store shoppers now have access to sick pay, an accrued benefit that can be used as paid time off for absences from work due to illness or injury. This pay accrual will be backdated from the start of the year for all in-store shoppers. Instacart is also offering 14 days of pay for any part-time employee and full-service shoppers who are diagnosed with Covid-19 or are under mandatory isolation or quarantine directed by local, state, or public health authority. This assist will be available for 30 days. Instacart has also introduced “Leave at my Door Delivery” to all customers across North America.

It is important that we minimize contact with others since daily things are changing in relation to Covid-19. However, delivery services are really stepping up to keep customers safe and, for that, we should all be grateful. Remember to support your local restaurants by requesting non-contact delivery!

 

Coronavirus and food safety: What you need to know

By Nailah John, Linda Golodner Food Safety and Nutrition Fellow

Perhaps some of the only good news about the Covid-19 is that food is not the primary way that the virus can be spread. According to Harvard Medical School, “We are still learning about transmission of COVID-19. It’s not clear if this is possible, but if so, it would be more likely to be the exception than the rule. That said, COVID-19 and other coronaviruses have been detected in the stool of certain patients, so we currently cannot rule out the possibility of occasional transmission from infected food handlers. The virus would likely be killed by cooking.”

Great, but not all foods can or are intended to be cooked – think of deli meats, cole slaw, potato salad, cheeses, salads, fresh fruits and vegetables, breads, pastry, butter, cream cheese; so if the mainstay of a deli or restaurant is “fresh” foods, spreading the virus is a real threat if the right precautions are taken.

And COVID-19 has made us all keenly aware of the importance of wiping surfaces and washing hands frequently, especially when handling food. We also know that COVID-19 can’t typically be transmitted from food or from food packaging. But we do have suggestions.

Food safety measures one should take:

  • Wash your hands the right way: Use plain soap and water- skip the antibacterial soap, scrub the backs of your hands, between your fingers and under your nails for about 20 seconds, if you need to time yourself sing the chorus of your favorite song twice. Rinse your hands, and then dry them with a clean towel. Remember to wash your hands often especially since COVID-19 lives on surfaces for an extended period.
  • Wash surfaces and utensils after each use: Wash cutting boards, utensils countertops with hot, soapy water, especially if you had raw meat, seafood, poultry or eggs on these surfaces. Don’t cross contaminate!
  • Remember it is very important to wash your dishcloths in a hot cycle of your washing machine, sometimes we forget this key element to food safety.
  • Learn more from FoodSafety.gov.

Food safety is paramount in our day-to-day lives – it’s so important that we take the necessary steps not to expose ourselves – whether eating in a restaurant or cooking at home, to COVID-19. Remember eat healthy, nutritious foods and take all the steps needed in preparing a safe meal for you and your family.

NCL statement: Thank you, quarantine workers

March 18, 2020

Media contact: National Consumers League – Carol McKay, carolm@nclnet.org, (412) 945-3242 or Taun Sterling, tauns@nclnet.org, (202) 207-2832 

Washington, DC—The National Consumers League joins with our fellow Americans, friends, colleagues, and families in as we adapt our lives to address the health crisis caused by COVID-19. NCL has long been a consumer and patient advocate and we strongly support research, scientific programs, and policy solutions to address diseases across the board.

We want to take this moment to say “thank you” to the thousands of public health servants going into the hospitals, doctors offices and clinics and working on the frontlines to save millions of lives. We rely and depend on their vast knowledge, dedication and commitment to treating sick patients, and we want to specially thank them during this unprecedented national health crisis.

We also thank so many other workers – those in drug stores, grocery stores, Post Offices, the food delivery drivers, taxi, bus and subway drivers, utility workers keeping our electricity, gas, and water systems intact. We owe all of them a debt of gratitude as so many of us are able to work from home; we depend on all of you and thank you for your service to the nation.

We also join with colleagues in the healthcare advocacy community to thank infectious disease specialist Dr. Anthony Fauci for his extraordinary and selfless leadership in this battle against the spread of the coronavirus.

Join us on social to say #ThankYouDrFauci.

###

About the National Consumers League

The National Consumers League, founded in 1899, is America’s pioneering consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.